Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176734 | SCV000228442 | benign | not specified | 2015-05-12 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000266158 | SCV000418297 | likely benign | Inherited Erythromelalgia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000385041 | SCV000418299 | benign | Paroxysmal extreme pain disorder | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000288513 | SCV000418300 | likely benign | Channelopathy-associated congenital insensitivity to pain, autosomal recessive | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000327080 | SCV000418301 | benign | Primary erythromelalgia | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000442067 | SCV000511585 | benign | not provided | 2017-01-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000442067 | SCV000514592 | likely benign | not provided | 2020-08-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082772 | SCV000559276 | benign | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000442067 | SCV000615132 | likely benign | not provided | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000442067 | SCV004147196 | likely benign | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | SCN9A: BS2 |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000442067 | SCV001954358 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000442067 | SCV001974326 | likely benign | not provided | no assertion criteria provided | clinical testing |